Drugs / H1N1 vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00978120 | Oct 2009 → Sep 2010 | swine influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01111162 | Dec 2009 → Mar 2010 | HIV infectious disease | University of Pennsylvania | Completed | No outcome recorded |
| Phase 4 | NCT01842997 | Oct 2009 → Dec 2010 | influenza | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H1N1 vaccine | “INTERVENTION: Single intramuscular 15 microg dose of the monovalent, unadjuvanted, inactivated, split virus H1N1 vaccine.” PMID 20616698 ↗ Sep 2010 |
| Known as | influenza A(H1N1) vaccine | “To monitor and evaluate the safety of the influenza A(H1N1) vaccine in pregnant women and its influence on the fetus and neonate, we performed a prospective study in which 122...” PMID 24990911 ↗ Jul 2014 |
| Modality | Vaccine | “unadjuvanted, inactivated 2009 H1N1 vaccine” PMID 21145578 ↗ Dec 2010 |
| Route | Intramuscular | “intramuscular injections” NCT00978120 ↗ |